{"entity":{"type":"insider","cik":"0001378656","url":"/insider/0001378656","json_url":"/insider/0001378656.json","name":"O'Keeffe Charles B","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":35,"n_filings":33,"first":"2007-08-30","last":"2022-11-17","span_basis":"filed_date"},"name_variants":[{"name":"O'Keeffe Charles B","source":"filing","n_filings":33,"first_seen":"2007-08-30","last_seen":"2022-11-17"}],"transactions":[{"id":6887828,"accession":"0001161697-22-000554","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-22-000554","line_url":"/filing/0001161697-22-000554#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378656","owner_name":"O'Keeffe Charles B","owner_display_name":"O'Keeffe Charles B","owner_url":"/insider/0001378656","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":87985.0,"shares_display":"87,985","price_per_share":16.037,"price_display":"16.04","price_state":"stated","total_value":1411015.445,"total_display":"1,411,015.44","total_whole":"1,411,015","shares_owned_after":565057.0,"shares_owned_after_display":"565,057","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-15","filed_date":"2022-11-17","scope":"insider"},{"id":3084388,"accession":"0001161697-20-000418","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-20-000418","line_url":"/filing/0001161697-20-000418#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378656","owner_name":"O'Keeffe Charles B","owner_display_name":"O'Keeffe Charles B","owner_url":"/insider/0001378656","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7000.0,"shares_display":"7,000","price_per_share":2.99,"price_display":"2.99","price_state":"stated","total_value":20930.0,"total_display":"20,930.00","total_whole":"20,930","shares_owned_after":560376.0,"shares_owned_after_display":"560,376","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-30","filed_date":"2020-09-30","scope":"insider"},{"id":8709983,"accession":"0001161697-19-000434","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-19-000434","line_url":"/filing/0001161697-19-000434#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378656","owner_name":"O'Keeffe Charles B","owner_display_name":"O'Keeffe Charles B","owner_url":"/insider/0001378656","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":4.695,"price_display":"4.70","price_state":"stated","total_value":46950.0,"total_display":"46,950.00","total_whole":"46,950","shares_owned_after":553376.0,"shares_owned_after_display":"553,376","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-11","filed_date":"2019-10-11","scope":"insider"},{"id":6095665,"accession":"0001161697-18-000579","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-18-000579","line_url":"/filing/0001161697-18-000579#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378656","owner_name":"O'Keeffe Charles B","owner_display_name":"O'Keeffe Charles B","owner_url":"/insider/0001378656","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":2.5,"price_display":"2.50","price_state":"stated","total_value":50000.0,"total_display":"50,000.00","total_whole":"50,000","shares_owned_after":543376.0,"shares_owned_after_display":"543,376","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-14","filed_date":"2018-12-14","scope":"insider"},{"id":6135683,"accession":"0001161697-18-000306","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-18-000306","line_url":"/filing/0001161697-18-000306#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378656","owner_name":"O'Keeffe Charles B","owner_display_name":"O'Keeffe Charles B","owner_url":"/insider/0001378656","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":3.3055,"price_display":"3.31","price_state":"stated","total_value":13222.0,"total_display":"13,222.00","total_whole":"13,222","shares_owned_after":522376.0,"shares_owned_after_display":"522,376","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-07","filed_date":"2018-06-07","scope":"insider"},{"id":6095664,"accession":"0001161697-18-000308","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-18-000308","line_url":"/filing/0001161697-18-000308#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378656","owner_name":"O'Keeffe Charles B","owner_display_name":"O'Keeffe Charles B","owner_url":"/insider/0001378656","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":3.3523,"price_display":"3.35","price_state":"stated","total_value":3352.3,"total_display":"3,352.30","total_whole":"3,352","shares_owned_after":523376.0,"shares_owned_after_display":"523,376","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-07","filed_date":"2018-06-08","scope":"insider"},{"id":6578002,"accession":"0001161697-18-000302","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-18-000302","line_url":"/filing/0001161697-18-000302#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378656","owner_name":"O'Keeffe Charles B","owner_display_name":"O'Keeffe Charles B","owner_url":"/insider/0001378656","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":3.736,"price_display":"3.74","price_state":"stated","total_value":18680.0,"total_display":"18,680.00","total_whole":"18,680","shares_owned_after":518376.0,"shares_owned_after_display":"518,376","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-01","filed_date":"2018-06-01","scope":"insider"},{"id":2090323,"accession":"0001161697-16-000976","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-16-000976","line_url":"/filing/0001161697-16-000976#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378656","owner_name":"O'Keeffe Charles B","owner_display_name":"O'Keeffe Charles B","owner_url":"/insider/0001378656","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.8136,"price_display":"0.81","price_state":"stated","total_value":16272.0,"total_display":"16,272.00","total_whole":"16,272","shares_owned_after":432126.0,"shares_owned_after_display":"432,126","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-12","filed_date":"2016-07-12","scope":"insider"},{"id":2912450,"accession":"0001161697-16-000799","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-16-000799","line_url":"/filing/0001161697-16-000799#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378656","owner_name":"O'Keeffe Charles B","owner_display_name":"O'Keeffe Charles B","owner_url":"/insider/0001378656","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.596,"price_display":"0.60","price_state":"stated","total_value":11920.0,"total_display":"11,920.00","total_whole":"11,920","shares_owned_after":412126.0,"shares_owned_after_display":"412,126","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-26","filed_date":"2016-04-27","scope":"insider"},{"id":2350702,"accession":"0001161697-16-000734","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-16-000734","line_url":"/filing/0001161697-16-000734#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378656","owner_name":"O'Keeffe Charles B","owner_display_name":"O'Keeffe Charles B","owner_url":"/insider/0001378656","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.1062,"price_display":"1.11","price_state":"stated","total_value":11062.0,"total_display":"11,062.00","total_whole":"11,062","shares_owned_after":392126.0,"shares_owned_after_display":"392,126","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-16","filed_date":"2016-03-16","scope":"insider"},{"id":2672309,"accession":"0001161697-16-000655","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-16-000655","line_url":"/filing/0001161697-16-000655#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378656","owner_name":"O'Keeffe Charles B","owner_display_name":"O'Keeffe Charles B","owner_url":"/insider/0001378656","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.865,"price_display":"1.86","price_state":"stated","total_value":9325.0,"total_display":"9,325.00","total_whole":"9,325","shares_owned_after":382126.0,"shares_owned_after_display":"382,126","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-01","filed_date":"2016-02-01","scope":"insider"},{"id":3126035,"accession":"0001161697-16-000612","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-16-000612","line_url":"/filing/0001161697-16-000612#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378656","owner_name":"O'Keeffe Charles B","owner_display_name":"O'Keeffe Charles B","owner_url":"/insider/0001378656","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.937,"price_display":"1.94","price_state":"stated","total_value":9685.0,"total_display":"9,685.00","total_whole":"9,685","shares_owned_after":377126.0,"shares_owned_after_display":"377,126","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-08","filed_date":"2016-01-11","scope":"insider"},{"id":8327748,"accession":"0001161697-15-000568","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-15-000568","line_url":"/filing/0001161697-15-000568#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378656","owner_name":"O'Keeffe Charles B","owner_display_name":"O'Keeffe Charles B","owner_url":"/insider/0001378656","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.4087,"price_display":"2.41","price_state":"stated","total_value":12043.5,"total_display":"12,043.50","total_whole":"12,044","shares_owned_after":372126.0,"shares_owned_after_display":"372,126","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-23","filed_date":"2015-12-23","scope":"insider"},{"id":8501739,"accession":"0001161697-15-000511","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-15-000511","line_url":"/filing/0001161697-15-000511#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378656","owner_name":"O'Keeffe Charles B","owner_display_name":"O'Keeffe Charles B","owner_url":"/insider/0001378656","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.2964,"price_display":"2.30","price_state":"stated","total_value":11482.0,"total_display":"11,482.00","total_whole":"11,482","shares_owned_after":367126.0,"shares_owned_after_display":"367,126","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-19","filed_date":"2015-11-19","scope":"insider"},{"id":8800780,"accession":"0001161697-15-000418","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-15-000418","line_url":"/filing/0001161697-15-000418#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378656","owner_name":"O'Keeffe Charles B","owner_display_name":"O'Keeffe Charles B","owner_url":"/insider/0001378656","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.85,"price_display":"2.85","price_state":"stated","total_value":28500.0,"total_display":"28,500.00","total_whole":"28,500","shares_owned_after":362126.0,"shares_owned_after_display":"362,126","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-01","filed_date":"2015-10-01","scope":"insider"},{"id":8450690,"accession":"0001161697-15-000199","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-15-000199","line_url":"/filing/0001161697-15-000199#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICAL PARTNERS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378656","owner_name":"O'Keeffe Charles B","owner_display_name":"O'Keeffe Charles B","owner_url":"/insider/0001378656","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":3.294,"price_display":"3.29","price_state":"stated","total_value":32940.0,"total_display":"32,940.00","total_whole":"32,940","shares_owned_after":322126.0,"shares_owned_after_display":"322,126","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-30","filed_date":"2015-04-30","scope":"insider"},{"id":8252653,"accession":"0001161697-15-000193","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-15-000193","line_url":"/filing/0001161697-15-000193#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICAL PARTNERS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378656","owner_name":"O'Keeffe Charles B","owner_display_name":"O'Keeffe Charles B","owner_url":"/insider/0001378656","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":3.7999,"price_display":"3.80","price_state":"stated","total_value":18999.5,"total_display":"18,999.50","total_whole":"19,000","shares_owned_after":312126.0,"shares_owned_after_display":"312,126","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-24","filed_date":"2015-04-24","scope":"insider"},{"id":8062465,"accession":"0001161697-15-000011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-15-000011","line_url":"/filing/0001161697-15-000011#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICAL PARTNERS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378656","owner_name":"O'Keeffe Charles B","owner_display_name":"O'Keeffe Charles B","owner_url":"/insider/0001378656","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.9984,"price_display":"3.00","price_state":"stated","total_value":29984.0,"total_display":"29,984.00","total_whole":"29,984","shares_owned_after":307126.0,"shares_owned_after_display":"307,126","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-13","filed_date":"2015-01-13","scope":"insider"},{"id":6302658,"accession":"0001161697-14-000213","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-14-000213","line_url":"/filing/0001161697-14-000213#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICAL PARTNERS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378656","owner_name":"O'Keeffe Charles B","owner_display_name":"O'Keeffe Charles B","owner_url":"/insider/0001378656","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.8291,"price_display":"1.83","price_state":"stated","total_value":18291.0,"total_display":"18,291.00","total_whole":"18,291","shares_owned_after":192126.0,"shares_owned_after_display":"192,126","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-19","filed_date":"2014-05-21","scope":"insider"},{"id":6454017,"accession":"0001161697-14-000162","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-14-000162","line_url":"/filing/0001161697-14-000162#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICAL PARTNERS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378656","owner_name":"O'Keeffe Charles B","owner_display_name":"O'Keeffe Charles B","owner_url":"/insider/0001378656","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.0199,"price_display":"2.02","price_state":"stated","total_value":10099.5,"total_display":"10,099.50","total_whole":"10,100","shares_owned_after":182126.0,"shares_owned_after_display":"182,126","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-16","filed_date":"2014-04-17","scope":"insider"},{"id":6693699,"accession":"0001161697-14-000070","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-14-000070","line_url":"/filing/0001161697-14-000070#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICAL PARTNERS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378656","owner_name":"O'Keeffe Charles B","owner_display_name":"O'Keeffe Charles B","owner_url":"/insider/0001378656","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.8099,"price_display":"1.81","price_state":"stated","total_value":18099.0,"total_display":"18,099.00","total_whole":"18,099","shares_owned_after":177126.0,"shares_owned_after_display":"177,126","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-05","filed_date":"2014-02-06","scope":"insider"},{"id":4904954,"accession":"0001161697-13-000787","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-13-000787","line_url":"/filing/0001161697-13-000787#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICAL PARTNERS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378656","owner_name":"O'Keeffe Charles B","owner_display_name":"O'Keeffe Charles B","owner_url":"/insider/0001378656","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.8392,"price_display":"1.84","price_state":"stated","total_value":18392.0,"total_display":"18,392.00","total_whole":"18,392","shares_owned_after":167126.0,"shares_owned_after_display":"167,126","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-21","filed_date":"2013-10-21","scope":"insider"},{"id":2846809,"accession":"0001161697-12-000867","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-12-000867","line_url":"/filing/0001161697-12-000867#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICAL PARTNERS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378656","owner_name":"O'Keeffe Charles B","owner_display_name":"O'Keeffe Charles B","owner_url":"/insider/0001378656","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":0.419,"price_display":"0.42","price_state":"stated","total_value":10475.0,"total_display":"10,475.00","total_whole":"10,475","shares_owned_after":157126.0,"shares_owned_after_display":"157,126","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-15","filed_date":"2012-11-15","scope":"insider"},{"id":3076296,"accession":"0001161697-12-000443","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-12-000443","line_url":"/filing/0001161697-12-000443#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICAL PARTNERS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378656","owner_name":"O'Keeffe Charles B","owner_display_name":"O'Keeffe Charles B","owner_url":"/insider/0001378656","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.57,"price_display":"0.57","price_state":"stated","total_value":11400.0,"total_display":"11,400.00","total_whole":"11,400","shares_owned_after":132126.0,"shares_owned_after_display":"132,126","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-06-01","filed_date":"2012-06-01","scope":"insider"},{"id":3483771,"accession":"0001161697-12-000412","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-12-000412","line_url":"/filing/0001161697-12-000412#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICAL PARTNERS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378656","owner_name":"O'Keeffe Charles B","owner_display_name":"O'Keeffe Charles B","owner_url":"/insider/0001378656","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":31250.0,"shares_display":"31,250","price_per_share":0.8,"price_display":"0.80","price_state":"stated","total_value":25000.0,"total_display":"25,000.00","total_whole":"25,000","shares_owned_after":112126.0,"shares_owned_after_display":"112,126","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-24","filed_date":"2012-05-29","scope":"insider"},{"id":7681562,"accession":"0001161697-10-000608","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-10-000608","line_url":"/filing/0001161697-10-000608#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"Catalyst Pharmaceutical Partners, Inc.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378656","owner_name":"O'Keeffe Charles B","owner_display_name":"O'Keeffe Charles B","owner_url":"/insider/0001378656","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":1.0495,"price_display":"1.05","price_state":"stated","total_value":2099.0,"total_display":"2,099.00","total_whole":"2,099","shares_owned_after":80876.0,"shares_owned_after_display":"80,876","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-06-17","filed_date":"2010-06-30","scope":"insider"},{"id":7231339,"accession":"0001161697-10-000232","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-10-000232","line_url":"/filing/0001161697-10-000232#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"Catalyst Pharmaceutical Partners, Inc.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378656","owner_name":"O'Keeffe Charles B","owner_display_name":"O'Keeffe Charles B","owner_url":"/insider/0001378656","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.7209,"price_display":"0.72","price_state":"stated","total_value":3604.5,"total_display":"3,604.50","total_whole":"3,605","shares_owned_after":78876.0,"shares_owned_after_display":"78,876","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-18","filed_date":"2010-03-18","scope":"insider"},{"id":5875670,"accession":"0001161697-09-001163","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-09-001163","line_url":"/filing/0001161697-09-001163#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"Catalyst Pharmaceutical Partners, Inc.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378656","owner_name":"O'Keeffe Charles B","owner_display_name":"O'Keeffe Charles B","owner_url":"/insider/0001378656","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.73,"price_display":"0.73","price_state":"stated","total_value":7300.0,"total_display":"7,300.00","total_whole":"7,300","shares_owned_after":73876.0,"shares_owned_after_display":"73,876","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-17","filed_date":"2009-11-18","scope":"insider"},{"id":3356671,"accession":"0001161697-08-001271","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001161697-08-001271","line_url":"/filing/0001161697-08-001271","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"Catalyst Pharmaceutical Partners, Inc.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378656","owner_name":"O'Keeffe Charles B","owner_display_name":"O'Keeffe Charles B","owner_url":"/insider/0001378656","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4900.0,"shares_display":"4,900","price_per_share":2.202642857142857,"price_display":"2.20","price_state":"stated","total_value":10792.95,"total_display":"10,792.95","total_whole":"10,793","shares_owned_after":63876.0,"shares_owned_after_display":"63,876","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-20","filed_date":"2008-11-24","scope":"insider","n_lines":2},{"id":3356660,"accession":"0001161697-08-001271","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-08-001271","line_url":"/filing/0001161697-08-001271#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"Catalyst Pharmaceutical Partners, Inc.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378656","owner_name":"O'Keeffe Charles B","owner_display_name":"O'Keeffe Charles B","owner_url":"/insider/0001378656","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":2.315,"price_display":"2.32","price_state":"stated","total_value":463.0,"total_display":"463.00","total_whole":"463","shares_owned_after":58976.0,"shares_owned_after_display":"58,976","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-10-30","filed_date":"2008-11-24","scope":"insider"},{"id":3405877,"accession":"0001161697-08-000084","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-08-000084","line_url":"/filing/0001161697-08-000084#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"Catalyst Pharmaceutical Partners, Inc.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378656","owner_name":"O'Keeffe Charles B","owner_display_name":"O'Keeffe Charles B","owner_url":"/insider/0001378656","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":3.05,"price_display":"3.05","price_state":"stated","total_value":15250.0,"total_display":"15,250.00","total_whole":"15,250","shares_owned_after":58776.0,"shares_owned_after_display":"58,776","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-01-24","filed_date":"2008-01-28","scope":"insider"},{"id":7945003,"accession":"0001161697-07-001326","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-07-001326","line_url":"/filing/0001161697-07-001326#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"Catalyst Pharmaceutical Partners, Inc.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378656","owner_name":"O'Keeffe Charles B","owner_display_name":"O'Keeffe Charles B","owner_url":"/insider/0001378656","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.5,"price_display":"2.50","price_state":"stated","total_value":12500.0,"total_display":"12,500.00","total_whole":"12,500","shares_owned_after":53776.0,"shares_owned_after_display":"53,776","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-16","filed_date":"2007-11-20","scope":"insider"},{"id":8034138,"accession":"0001161697-07-001246","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-07-001246","line_url":"/filing/0001161697-07-001246#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"Catalyst Pharmaceutical Partners, Inc.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378656","owner_name":"O'Keeffe Charles B","owner_display_name":"O'Keeffe Charles B","owner_url":"/insider/0001378656","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4924.0,"shares_display":"4,924","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":14772.0,"total_display":"14,772.00","total_whole":"14,772","shares_owned_after":48776.0,"shares_owned_after_display":"48,776","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-01","filed_date":"2007-11-08","scope":"insider"},{"id":7721479,"accession":"0001161697-07-001017","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-07-001017","line_url":"/filing/0001161697-07-001017#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"Catalyst Pharmaceutical Partners, Inc.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378656","owner_name":"O'Keeffe Charles B","owner_display_name":"O'Keeffe Charles B","owner_url":"/insider/0001378656","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":76.0,"shares_display":"76","price_per_share":2.75,"price_display":"2.75","price_state":"stated","total_value":209.0,"total_display":"209.00","total_whole":"209","shares_owned_after":43852.0,"shares_owned_after_display":"43,852","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-29","filed_date":"2007-08-30","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":35,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":34,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":35},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001369568","name":"CATALYST PHARMACEUTICALS, INC.","url":"/issuer/0001369568","role":"Director","n_filings":33,"first_seen":"2007-08-30","last_seen":"2022-11-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001378656","retrieved_at":"2026-08-24T11:19:21+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}